Analyst Expectations For Agilon Health's Future

4 analysts have shared their evaluations of Agilon Health AGL during the recent three months, expressing a mix of bullish and bearish perspectives.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $11.5, a high estimate of $18.00, and a low estimate of $9.00. Observing a downward trend, the current average is 31.01% lower than the prior average price target of $16.67.

Deciphering Analyst Ratings: An In-Depth Analysis

The analysis of recent analyst actions sheds light on the perception of Agilon Health by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Agilon Health. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Agilon Health compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Agilon Health's stock. This examination reveals shifts in analysts' expectations over time.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Agilon Health's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Agilon Health analyst ratings.

All You Need to Know About Agilon Health

Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.

A Deep Dive into Agilon Health's Financials

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Over the 3 months period, Agilon Health showcased positive performance, achieving a revenue growth rate of 74.95% as of 30 September, 2023. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Agilon Health's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -2.59%, the company may encounter challenges in effective cost control.

Return on Equity (ROE): Agilon Health's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -3.59%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): Agilon Health's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.36%, the company may encounter challenges in delivering satisfactory returns from its assets.

Debt Management: Agilon Health's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.06.

The Core of Analyst Ratings: What Every Investor Should Know

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.